MedDataX Logo

Reciting Tang Poems to Promote Happiness

NCT06057142 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2025-09-16

No results posted yet for this study

Summary

The ethnic minority population is increasing Hong Kong. Language learning is usually measured as one of the core indicators of acculturation. Chinese Tang poems use a specific mirror symmetry that could make people acquire unconscious learning. The goal of this pilot pre-post interventional trial with no controls is to explore the feasibility and preliminary evidence of the effectiveness of using fun activities for Tang poem reading to promote reciting and happiness in primary school ethnic minority and their families. Participants will be invited to participate in three Tang poetry recitation sessions and one participant performance session. The hypothesis is that participants with a greater number of successful recited poems will show higher happiness and enjoyment by students.

Conditions

  • Acculturation
  • Happiness
  • Well-Being, Psychological
  • Ethnic Minority

Interventions

BEHAVIORAL

Fun activities for reciting Tang poems

The students will participate in three weekly sessions of Tang poem classes and one session of performance show. Each session lasts for 1.5 hours. Parents can sit in the class. A total of six poems will be taught by two experienced Chinese teachers.

Sponsors & Collaborators

  • Bestreben Drama Association Limited

    collaborator UNKNOWN

  • Hong Kong Metropolitan University

    lead OTHER

Principal Investigators

  • Yuying Sun, PhD · Hong Kong Metropolitan University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-06
Primary Completion
2025-04-30
Completion
2025-06-30

Countries

  • Hong Kong

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06057142 on ClinicalTrials.gov